Afatinib, an EGFR/Her-2 dual inhibitor, effectively radiosensitizes bladder cancer cells

被引：0
|
作者：
Tsai, Yu-Chieh [1 ]
Chen, Jason Chia-Hsien [1 ]
Tuan, Tsung-Fan [1 ]
Yeh, Chih-Hsien [1 ]
Ho, Pei-Yin [2 ]
Pu, Yeong-Shiau [1 ]
Cheng, Ann-Lii [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
[2] Natl Taiwan Univ, Taipei 10764, Taiwan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1464
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1464
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discovery of a novel dual EGFR/HER-2 inhibitor
    不详
    PHARMACOGENOMICS, 2010, 11 (06) : 745 - 745
  • [2] Discovery of a potent dual EGFR/HER-2 inhibitor L-2 (selatinib) for the treatment of cancer
    Zhang, Long
    Fan, Chuanwen
    Guo, Zongru
    Li, Ying
    Zhao, Shuyong
    Yang, Shaobo
    Yang, Yingying
    Zhu, Jianrong
    Lin, Dong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 69 : 833 - 841
  • [3] EFFICACY OF THE IRREVERSIBLE EGFR-HER2 DUAL INHIBITOR AFATINIB IN PRETREATED LUNG ADENOCARCINOMA
    Landi, L.
    Galetta, D.
    Bennati, C.
    Curra, F.
    Chiari, R.
    Metro, G.
    D'Arcangelo, M.
    Marchetti, A.
    Cappuzzo, F.
    Crino, L.
    ANNALS OF ONCOLOGY, 2012, 23 : 423 - 423
  • [4] Dual targeting of EGFR and HER-2 in colon cancer cell lines
    Efstathia Giannopoulou
    Anna Antonacopoulou
    Konstantina Floratou
    Athanasios G. Papavassiliou
    Haralabos P. Kalofonos
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 973 - 981
  • [5] Dual targeting of EGFR and HER-2 in colon cancer cell lines
    Giannopoulou, Efstathia
    Antonacopoulou, Anna
    Floratou, Konstantina
    Papavassiliou, Athanasios G.
    Kalofonos, Haralabos P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 973 - 981
  • [6] Dual targeting of EGFR and HER-2 in colon cancer cell lines
    Giannopoulou, E.
    Antonacopoulou, A.
    Floratou, K.
    Kalofonos, H.
    FEBS JOURNAL, 2008, 275 : 306 - 306
  • [7] Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model
    Diaz, Roque
    Nguewa, Paul A.
    Parrondo, Ricardo
    Perez-Stable, Carlos
    Manrique, Irene
    Redrado, Miriam
    Catena, Raul
    Collantes, Maria
    Penuelas, Ivan
    Antonio Diaz-Gonzalez, Juan
    Calvo, Alfonso
    BMC CANCER, 2010, 10
  • [8] Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model
    Roque Diaz
    Paul A Nguewa
    Ricardo Parrondo
    Carlos Perez-Stable
    Irene Manrique
    Miriam Redrado
    Raul Catena
    Maria Collantes
    Ivan Peñuelas
    Juan Antonio Díaz-González
    Alfonso Calvo
    BMC Cancer, 10
  • [9] Dual HER-2/EGFR tyrosine kinase inhibitors
    Cardoso F.
    Breast Cancer Research, 3 (1)
  • [10] EGFR and HER-2 antagonists in breast cancer
    O'Donovan, Norma
    Browne, Brigid
    Crown, John
    Duffy, Michael J.
    Slamon, Dennis
    Clynes, Martin
    ANTICANCER RESEARCH, 2007, 27 (3A) : 1374 - 1374
12345